Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma

被引：7
|
作者：
Beasley, Richard [1 ,2 ]
Fingleton, James [1 ,2 ]
Weatherall, Mark [2 ,3 ]
机构：
[1] Med Res Inst New Zealand, Dept Internal Med, Wellington 6242, New Zealand
[2] Capital & Coast Dist Hlth Board, Dept Internal Med, Wellington, New Zealand
[3] Univ Otago Wellington, Dept Med, Wellington, New Zealand
来源：
THORAX | 2013年 / 68卷 / 02期
关键词：
RANDOMIZED CONTROLLED-TRIALS; FLUTICASONE PROPIONATE; EXTERNAL VALIDITY; SALMETEROL; CORTICOSTEROIDS; ADHERENCE; ADULTS; RISK; METAANALYSIS; MORTALITY;
D O I：
10.1136/thoraxjnl-2012-202483
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：119 / 120
页数：2
相关论文
共 50 条
  • [21] When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment
    Cheng, Wen-Chien
    Wu, Biing-Ru
    Liao, Wei-Chih
    Chen, Chih-Yu
    Chen, Wei-Chun
    Hsia, Te-Chun
    Tu, Chih-Yen
    Chen, Chia-Hung
    Hsu, Wu-Huei
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 3375 - 3384
  • [22] Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
    Koarai, Akira
    Yamada, Mitsuhiro
    Ichikawa, Tomohiro
    Fujino, Naoya
    Kawayama, Tomotaka
    Sugiura, Hisatoshi
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [23] Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database
    Quint, Jennifer K.
    Montonen, Jukka
    Esposito, Daina B.
    He, Xintong
    Koerner, Leslie
    Wallace, Laura
    de la Hoz, Alberto
    Miravitlles, Marc
    ADVANCES IN THERAPY, 2021, 38 (05) : 2249 - 2270
  • [24] Retrospective Analysis of the Starting Dose of Combined ICS/LABA for Cough-variant Asthma and Cough-predominant Asthma
    Nakajima, Takeo
    Nagano, Tatsuya
    Nishimura, Yoshihiro
    IN VIVO, 2022, 36 (02): : 949 - 953
  • [25] Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD Cohort Study in Real-World Clinical Practice
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    CHEST, 2020, 157 (04) : 846 - 855
  • [26] Evolving to a single inhaler extrafine LABA/LAMA/ICS - Inhalation technique and adherence at the heart of COPD patient care (TRIVOLVE)
    Brusselle, G.
    Himpe, U.
    Fievez, P.
    Leys, M.
    Bogerd, S. Perez
    Peche, R.
    Vanderhelst, E.
    Lins, M.
    RESPIRATORY MEDICINE, 2023, 218
  • [27] Real-life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred-dose inhalers in patients with asthma treated with ICS/LABA
    Park, Hae-Sim
    Yoon, Dukyong
    Lee, Hyun Young
    Ban, Ga-Young
    Ming, Simon Wan Yau
    Jie, Joanna Ling Zhi
    Carter, Victoria
    Hardjojo, Antony
    Van Boven, Job F. M.
    Price, David B.
    RESPIROLOGY, 2019, 24 (10) : 972 - 979
  • [28] Use of ICS/LABA (extra-fine and non-extra-fine) in elderly asthmatics
    Benfante, Alida
    Basile, Marco
    Battaglia, Salvatore
    Spatafora, Mario
    Scichilone, Nicola
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1553 - 1562
  • [29] Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia
    Reddel, Helen K.
    Beckert, Lutz
    Moran, Angela
    Ingham, Tristram
    Ampon, Rosario D.
    Peters, Matthew J.
    Sawyer, Susan M.
    RESPIROLOGY, 2017, 22 (08) : 1570 - 1578
  • [30] Persistence and Adherence to ICS/LABA Drugs in UK Patients with Asthma: A Retrospective New-User Cohort Study
    Mounika Parimi
    Henrik Svedsater
    Quratul Ann
    Mugdha Gokhale
    Christen M. Gray
    David Hinds
    Mark Nixon
    Naomi Boxall
    Advances in Therapy, 2020, 37 : 2916 - 2931
12345